May 2011
Reactions of 2-(Diformylmethylidene)-3,3-dimethylindole with Hydrazides: Synthesis of New
669
Pyrazolylindolenine Derivatives—The Unprecedented One-Pot Pyrazole–Thiadiazole Double Annulation
3,3-Dimethyl-2-(1H-pyrazol-4-yl)-3H-indolium chloride
(7). Yield: 0.37 g, 75%. mp 266–268ꢁC; IR (KBr, cmꢂ1):
3084, 1611, 1593, 1244, 1154, 762; 1H NMR (DMSO-d6): d
1.68 (s, 6H, CH3), 7.44–7.53 (m, 2H, indolenine-H), 7.66 (d,
1H, J ¼ 7.6 Hz, indolenine-H), 7.76 (d, 1H, J ¼ 7.2 Hz, indole-
nine-H), 9.06 (s, 2H, pyrazolyl-H); 13C NMR (DMSO-d6): d
23.94, 52.57, 109.38, 115.56, 122.93, 127.46, 128.73, 138.52,
141.01, 142.86, 179.64; Anal. Calcd for C13H14ClN3: C, 63.03;
H, 5.70; N, 16.96%. Found: C, 62.90; H, 5.89; N, 16.81%.
Reaction with thiosemicarbazide. A solution of the dialde-
hyde (1; 0.43 g, 2 mmol) and thiosemicarbazide (0.182 g, 2
mmol) in ethanol (20 mL) in the presence of acetic acid (0.5
mL) refluxed for 1 h. The solvent was evaporated, and the
resulting solid was dissolved in EtOAc:Hexane (7:3) and set
aside at room temperature. In a few hours, the yellow crystals
of the compound 9 were obtained. The crystals were collected,
and the solution was set aside for 1 day, whereupon the yellow
crystals of compound 8 were separated out.
5-[4-(3,3-Dimethyl-3H-indol-2-yl)-pyrazol-1-yl]-3H-[1,3,4]thia-
diazole-2-thione (12). Yield: 0.09 g, 14%. mp 312–314ꢁC; IR
(KBr, cmꢂ1): 3076, 2965, 1583, 1431, 1257, 1192, 1059, 739;
1H NMR (DMSO-d6): d 1.48 (s, 6H, CH3), 7.27 (m, 1H, indo-
lenine-H), 7.35 (m, 1H, indolenine-H), 7.53 (d, 1H, J ¼ 6.8
Hz, indolenine-H), 7.58 (d, 1H, J ¼ 7.2 Hz, indolenine-H),
8.58 (s, 1H, pyrazolyl-H), 9.14 (s, 1H, pyrazolyl-H), 10.58 (s,
1H, NH); 13C NMR (DMSO-d6): d 23.43, 52.91, 119.14,
120.07, 121.52, 125.73, 127.48, 127.72, 143.59, 146.82,
152.95, 153.08, 176.86, 186.17; Anal. Calcd for C15H13N5S2:
C, 55.02; H, 4.00; N, 21.39; S, 19.59%. Found: C, 54.77; H,
3.84; N, 21.75; S, 19.36%.
SUPPLEMENTARY DATA
Crystallography data (excluding structure factors) for
the structures in this article have been deposited with
the Cambridge Crystallographic Data Centre as supple-
mentary publication nos. CCDC. 764076–764085.
4-(3,3-Dimethyl-3H-indol-2-yl)-pyrazole-1-carbothioamide
(8). Yield: 0.34 g, 63%. mp 152–154ꢁC; IR (KBr, cmꢂ1):
3377, 3256, 2964, 1621, 1576, 1455, 1370, 1186, 1100, 974,
1
872, 757, 632; H NMR (DMSO-d6): d 1.44 (s, 6H, CH3), 7.25
Acknowledgment. The authors thank the University of
Malaya for funding this study (FRGS grant No. FP009/
2008 C).
(m, 1H, indolenine-H), 7.34 (m, 1H, indolenine-H), 7.52 (d, 1H,
J ¼ 7.2 Hz, indolenine-H), 7.56 (d, 1H, J ¼ 7.6 Hz, indolenine-
H), 8.52 (s, 1H, pyrazolyl-H), 9.15 (s, 1H, pyrazolyl-H), 9.72 (s,
1H, NH2), 10.20 (s, 1H, NH2); 13C NMR (CDCl3): d 24.51,
53.30, 119.86, 120.67, 121.06, 125.98, 127.98, 130.17, 143.57,
146.40, 153.39, 176.81, 177.69; MS: m/z 271 (MHþ); Anal.
Calcd for C14H14N4S: C, 62.20; H, 5.22; N, 20.72; S, 11.86%.
Found: C, 61.86; H, 5.08; N, 20.49; S, 11.71%.
3,3-Dimethyl-2-(1H-pyrazol-4-yl)-3H-indolium thiocyanate
(9). Yield: 0.15 g, 28%. mp 177–180ꢁC; IR (KBr, cmꢂ1):
3105, 2078, 1610, 1594, 1249, 1163, 944, 761; 1H NMR
(DMSO-d6): d 1.65 (s, 6H, CH3), 7.39–7.50 (m, 2H, indole-
nine-H), 7.58 (d, 1H, J ¼ 7.3 Hz, indolenine-H), 7.74 (d, 1H,
J ¼ 7.3 Hz, indolenine-H), 8.85 (s, 2H, pyrazolyl-H); 13C
NMR (DMSO-d6): d 25.49, 53.24, 110.14, 116.28, 123.50,
128.02, 129.35, 138.64, 141.96, 143.52, 180.75, 206.72; Anal.
Calcd for C14H14N4S: C, 62.20; H, 5.22; N, 20.72; S, 11.86%.
Found: C, 61.91; H, 5.41; N, 20.42; S, 11.60%.
Reaction with thiocarbohydrazide. A mixture of the dia-
ldehyde (1; 0.43 g, 2 mmol) and thiocarbohydrazide (0.318 g,
3 mmol) in ethanol (20 mL) in the presence of acetic acid (0.5
mL) was refluxed for 4 h during which the compound 12 pre-
cipitated out. It was filtered, washed with water and ethanol,
and dried over silica gel. A Suitable crystal for X-ray analysis
was obtained by recrystallization from DMSO. Compound 11
was separated out as a yellow solid on addition of water to the
filtrate and recrystallized from ethyl acetate to give the X-ray
quality crystals.
4-(3,3-Dimethyl-3H-indol-2-yl)-pyrazole-1-carbothioic acid
hydrazide (11). Yield: 0.31 g, 54%. mp 149–150ꢁC; IR (KBr,
cmꢂ1): 3260, 2965, 1579, 1540, 1454, 1358, 1246, 1165, 1014,
896, 750; 1H NMR (CDCl3): d 1.52 (s, 6H, CH3), 4.76 (bs,
2H, NH2), 7.25–7.39 (m, 3H, indolenine-H), 7.66 (d, 1H, J
¼7.2 Hz, indolenine-H), 8.40 (s, 1H, pyrazolyl-H), 9.05 (s,
1H, pyrazolyl-H), 9.97 (bs, 1H, NH); 13C NMR (CDCl3): d
24.56, 53.31, 118.98, 120.67, 121.07, 125.95, 128.01, 130.26,
143.19, 146.38, 153.49, 174.79, 176.90; MS: m/z 286 (MHþ);
Anal. Calcd for C14H15N5S: C, 58.92; H, 5.30; N, 24.54; S,
11.24%. Found: C, 58.49; H, 5.58; N, 24.23; S, 11.09%.
REFERENCES AND NOTES
[1] Lin, R.; Chiu, G.; Yu, Y.; Connolly, P. J.; Li, S.; Lu, Y.;
Adams, M.; Fuentes-Pesquera, A. R.; Emanuel, S. L.; Greenberger, L.
M. Bioorg Med Chem Lett 2007, 17, 4557.
[2] Gokhan-Kelekci, N.; Yabanoglu, S.; Kupeli, E.; Salgin, U.;
Ozgen, O.; Ucar, G.; Yesilada, E.; Kendi, E.; Yesilada, A.; Bilgin, A.
A. Bioorg Med Chem 2007, 15, 5775.
[3] Demirayak, S.; Karaburum, A. S.; Beis, R. Eur J Med
Chem 2004, 39, 1089.
´
[4] Barcelo, M.; Ravina, E.; Masaguer, C. F.; Dominguez, E.;
Areias, F. M.; Brea, J.; Loza, M. I. Bioorg Med Chem Lett 2007, 17,
4873.
[5] Camacho, M. E.; Leon, J.; Entrena, A.; Velasco, J.; Cfrrion,
M. D.; Escamaes, G.; Vivo, A.; Acuna-Castroviego, D.; Gallo, M. A.;
Espinosa, A. J Med Chem 2004, 47, 5641.
[6] (a) Wang, Z.; Qin, H. Green Chem. 2004, 6, 90, and refer-
ences cited there in; (b) Katritzky, A. R. Handbook of Heterocyclic
Chemistry; Pergamon: NewYork, 1985.
[7] Helliwell, M.; Afgan, A.; Baradarani, M. M.; Joule, J. A.
Acta Crystallogr Sect E 2006, 62, o737.
[8] Baradarani, M. M.; Afgan, A.; ZebarJadi, F.; Hasanzadeh
K.; Joule, J. A. J Heterocycl Chem 2006, 43, 1591.
[9] (a) Deslongchamps, P. Stereoelectronic Effects in Organic
Chemistry, 1st ed.; Pergamon: Oxford, 1983. (b) Bu¨rgi, H. B.; Dunitz,
J. D.; Lehn, J. M.; Wipff, G. Tetrahedron 1974, 30, 1563.
[10] Ali, M. A.; Tarafder, M. T. H. J Inorg Nucl Chem 1977,
39, 1785.
[11] (a) Evans, I. R.; Howard, J. A. K.; Howard, L. E. M.;
Evans, J. S. O.; Jacimovic, Z. K.; Jevtovic, V. S.; Leovac, V. M.
Inorg Chim Acta 2004, 357, 4528; (b) Treu, O.; Rocha, F. V.;
Netto, A. V. G.; Pinheiro, J. C.; Utuni, V. H. S.; Vegner, H. S.;
Kondo, R. T.; Mauro, A. E. J Mol Struct 2009, 921, 239; (c)
Casas, J. S.; Castellano, E. E.; Eduardo, E.; Ellena, J.; Garcia-Ta-
sende M. S.; Perez-Paralle, M. L.; Sanchez, A.; Sanchez-Gonzalez,
A.; Sordo, J.; Touceda, A. J Inorg Biochem 2008, 102, 33; (d)
Sharma, P. K.; Sawhney, S. N. Bull Chem Soc Jpn 1993, 66, 3843;
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet